Latest News
AstraZeneca gets European approval for Zurampic and Brilique
The European Commission has given AstraZeneca’s Zurampic drug marketing authorisation for the treatment of gout in the European Union.
Millennium & Copthorne profit hit by external factors
Millennium & Copthorne Hotels posted an 86% drop in fourth quarter pre-tax profit despite a slight gain in revenue.
Coca-Cola HBC rises above volatile rouble
A thirsty clientele saw volumes increase at Coca-Cola HBC in the year ended 31 December, and earnings were slightly ahead despite foreign exchange having an adverse impact on revenues.
Friday newspaper round-up: Cameron, UK interest rates, Facebook
European leaders were joining together to insert a “last chance” clause into David Cameron’s renegotiation deal last night, ensuring that Britain would never be allowed to reopen talks. In the surprise move, pushed by Belgium and backed by France, all 28 countries will insist that an agreement struck today is the maximum that can ever be offered to Britain. Although British officials stressed that the move had not been prompted by the prime minister, he is believed to support it as a way of convincing Eurosceptics that the deal on the table is the last and only offer.
Standard Life reports jump in profits
London open The Footsie is seen starting the day six points lower than Thursday's closing level of 5,971. 95.
Standard Life inflows rise despite tough markets
Standard Life bucked volatile global markets to post a 9% rise in pre-tax operating profits to £665m with a £38m reduction in the spread/risk margin and diluted operating EPS of 26. 1p.
London pre-open: Stocks seen little changed as investors eye retail sales
London stocks looked set to open little changed ahead of some closely-watched UK data releases.